MedTrace Logo

Pilot Testing a Novel Non-invasive Lactate Sensor

NCT05649358 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2023-10-05

No results posted yet for this study

Summary

To test the efficacy and accuracy of a novel non-invasive lactate sensor in humans undergoing strenuous leg exercise.

Conditions

  • Hyperlactatemia

Interventions

DEVICE

Lactate sensor (Lactisense)

Non-invasive monitoring of interstitial lactate levels during and after exercise.

Sponsors & Collaborators

  • University of Alberta

    lead OTHER

Principal Investigators

  • Peter E Light, PhD · University of Alberta

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-12-05
Primary Completion
2023-08-31
Completion
2023-09-25

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05649358 on ClinicalTrials.gov